Jade Biosciences Inc
(JBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 17,639 | 15,851 | 14,152 | 12,215 | 11,019 |
| Operating Income | -17,639 | -15,851 | -14,152 | -12,215 | -11,019 |
| Other Income | 1,119 | 854 | 564 | 224 | 109 |
| Pre-tax Income | -16,520 | -14,997 | -13,588 | -11,991 | -10,910 |
| Net Income Continuous | -16,520 | -15,022 | -13,588 | -11,991 | -10,910 |
| Net Income | $-16,520 | $-15,022 | $-13,588 | $-11,991 | $-10,910 |
| EPS Basic Total Ops | -23.51 | -21.05 | -19.65 | -17.19 | -15.79 |
| EPS Basic Continuous Ops | -23.39 | -21.44 | -19.50 | -17.24 | -15.68 |
| EPS Diluted Total Ops | -23.51 | -21.05 | -19.65 | -17.19 | -15.79 |
| EPS Diluted Continuous Ops | -23.39 | -21.44 | -19.50 | -17.24 | -15.68 |
| EBITDA(a) | $-18,289 | $-16,417 | $-14,424 | $-12,259 | $-10,979 |